Literature DB >> 21246732

Protein expression profiling in chemical carcinogenesis: a proteomic-based approach.

Simone Schmitz-Spanke1, Albert W Rettenmeier.   

Abstract

The simultaneous analysis of a wide array of proteins may provide valuable information on the activation and suppression of cellular systems at different stages of the exposure-disease continuum. In this review, results of proteomic studies in the field of toxicology are covered, focusing on the effects of chemical carcinogens. So far, alterations of highly abundant proteins have been identified which, irrespective of the wide differences in study design and technologies used, can be grossly assigned to three functional classes: proteins related to cellular stress response, inflammation, and stimulation of the immune system. It is obvious that the observed protein alterations are not causal factors in the development of chemically induced cancer but rather reflect common reactions to cellular perturbations. In order to gain deeper insights into the process of chemical carcinogenesis, the previously applied "shotgun" analyses have to be abandoned in favour of targeted proteomic approaches focusing on the accurate identification and quantification of selected proteins. Advanced analytical techniques such as selective reaction monitoring (SRM) and multiple reaction monitoring (MRM) offer this opportunity. If toxicoproteomic research moves into that direction and takes advantage of such techniques it will have the potential to contribute to the elucidation of chemical carcinogenesis.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21246732     DOI: 10.1002/pmic.201000403

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  5 in total

1.  Adseverin: a novel cisplatin-resistant marker in the human bladder cancer cell line HT1376 identified by quantitative proteomic analysis.

Authors:  Noriyoshi Miura; Nobuaki Takemori; Tadahiko Kikugawa; Nozomu Tanji; Shigeki Higashiyama; Masayoshi Yokoyama
Journal:  Mol Oncol       Date:  2012-01-04       Impact factor: 6.603

2.  Differential proteomic analysis of pathway biomarkers in human breast cancer by integrated bioinformatics.

Authors:  Liu Fu-Jun; Jin Shao-Hua; Shen Xiao-Fang
Journal:  Oncol Lett       Date:  2012-08-24       Impact factor: 2.967

3.  Atrazine affects phosphoprotein and protein expression in MCF-10A human breast epithelial cells.

Authors:  Peixin Huang; John Yang; Qisheng Song
Journal:  Int J Mol Sci       Date:  2014-10-01       Impact factor: 5.923

4.  Cross-platform toxicogenomics for the prediction of non-genotoxic hepatocarcinogenesis in rat.

Authors:  Michael Römer; Johannes Eichner; Ute Metzger; Markus F Templin; Simon Plummer; Heidrun Ellinger-Ziegelbauer; Andreas Zell
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

5.  Effects of water-soluble components of atmospheric particulates from rare earth mining areas in China on lung cancer cell cycle.

Authors:  Yuan Xia; Xulong Zhang; Dejun Sun; Yumin Gao; Xiaoe Zhang; Li Wang; Qingjun Cai; Qihao Wang; Juan Sun
Journal:  Part Fibre Toxicol       Date:  2021-08-02       Impact factor: 9.400

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.